GARDANI GIANSTEFANO

Ruolo: 
professore associato
Settore scientifico disciplinare: 
DIAGNOSTICA PER IMMAGINI E RADIOTERAPIA (MED/36)
Telefono: 
0392333463

Didattica

Pubblicazioni

  • Guerra, L., Meregalli, S., Zorz, A., Niespolo, R., De Ponti, E., Elisei, F., et al. (2014). Comparative evaluation of CT-based and respiratory-gated PET/CT-based planning target volume (PTV) in the definition of radiation treatment planning in lung cancer: preliminary results. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 41(4), 702-710. Dettaglio
  • Aristei, C., Santucci, A., Corvò, R., Gardani, G., Ricardi, U., Scarzello, G., et al. (2013). In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. BONE MARROW TRANSPLANTATION, 48(7), 908-914. Dettaglio
  • Meregalli, C., Guerra, L., Zorz, A., Bonetto, E., Brenna, S., Montanari, G., et al. (2013). Intracavitary Brachytherapy in Cervical Carcinoma: The Role of F18-FDGPET in Treatment Planning. JOURNAL OF NUCLEAR MEDICINE & RADIATION THERAPY(S6), 015. Dettaglio
  • Ippolito, D., Monguzzi, L., Guerra, L., Deponti, E., Gardani, G., Messa, C., et al. (2012). Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT. ABDOMINAL IMAGING, 37, 1032-1040. Dettaglio
  • Guerra, L., Niespolo, R., Di Pisa, G., Ippolito, D., De Ponti, E., Terrevazzi, S., et al. (2011). Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer. ABDOMINAL IMAGING, 36(1), 38-45. Dettaglio